RUXIENCE

Pfizer Inc.

Application Filed: 2018-07-02
Trademark Application Details
Trademark Logo RUXIENCE

Mark For: RUXIENCE® trademark registration is intended to cover the categories of pharmaceutical preparations for the treatment of autoimmune, and inflammatory diseases and disorders; pharmaceutical preparations for the treatment of cancer. [all]

Status

2021-07-18 UTC
LIVE REGISTRATION Issued and Active
The trademark application has been registered with the Office.


Research OneLook Acronym Finder
Serial Number88023071
Registration Number6175690
Mark Literal ElementsRUXIENCE
Mark Drawing Type4 - STANDARD CHARACTER MARK
Mark TypeTRADEMARK
RegisterPRINCIPAL
Current LocationPUBLICATION AND ISSUE SECTION 2020-09-08
Basis1(a)
Class StatusACTIVE
Primary US Classes
  • 006: Chemicals and Chemical Compositions
  • 018: Medicines and Pharmaceutical Preparations
  • 044: Dental, Medical and Surgical Appliances
  • 046: Foods and Ingredients of Foods
  • 051: Cosmetics and Toilet Preparations
  • 052: Detergents and Soaps
Primary International Class
  • 005 - Primary Class
  • (Pharmaceuticals) Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
Filed UseNo
Current UseYes
Intent To UseNo
Filed ITUYes
44D FiledNo
44E CurrentNo
66A CurrentNo
Current BasisNo
No BasisNo
Attorney NameRichard A. Friedman
Attorney Docket NumberT423495
Law Office AssignedM10
Employee NameKHOURI, SANI PHILIPPE

Timeline

2018-07-02Application Filed
2018-12-11Published
2018-12-11Published for Opposition
2019-02-05Location: INTENT TO USE SECTION
2019-07-30Status: Live/Pending
2019-08-01Transaction Date
2020-01-31Date of First Use
2020-01-31Date of Use In Commerce
2020-09-08Location: PUBLICATION AND ISSUE SECTION
2020-10-13Status: Registered. The registration date is used to determine when post-registration maintenance documents are due.
2020-10-13Trademark Registered

Trademark Parties (Applicants & Owners)

Party: Pfizer Inc.
Address235 East 42nd St. New York, NEW YORK UNITED STATES 10017
Legal Entity TypeCorporation
Legal Entity StateDELAWARE

Documents

DrawingJPEG2018-07-02
TEAS RF New ApplicationMULTI2018-07-02
XSearch Search SummaryXML2018-10-26
TRAM Snapshot of App at Pub for OppostnMULTI2018-10-27
Notice of PublicationXML2018-11-21
Notification Of Notice of PublicationXML2018-11-21
OG Publication ConfirmationXML2018-12-11
Notice of AllowanceXML2019-02-05
Extension of Time to File SOUXML2019-07-30
ITU Extension ApprovalAPPLICATION/XML2019-08-01
ITU Unit ActionAPPLICATION/XML,IMAGE/JPEG2019-08-01
Extension of Time to File SOUXML2020-01-10
ITU Extension ApprovalAPPLICATION/XML2020-01-14
ITU Unit ActionAPPLICATION/XML,IMAGE/JPEG2020-01-14
Extension of Time to File SOUXML2020-07-24
ITU Extension ApprovalXML2020-07-28
ITU Unit ActionMULTI2020-07-28
SpecimenJPEG2020-08-12
Statement of UseMULTI2020-08-12
ITU Unit ActionMULTI2020-08-27
Notice of Acceptance of Statement of UseAPPLICATION/XML2020-09-09
TRAM Snapshot of App at Pub for OppostnMULTI2020-09-09
Registration CertificatePDF2020-10-13

Attorney of Record

RICHARD A. FRIEDMAN
PFIZER INC.
235 EAST 42ND ST.
NEW YORK, NY 10017

Good, Services, and Codes


IC 005. US 006 018 044 046 051 052. G & S: Pharmaceutical preparations for the treatment of autoimmune, and inflammatory diseases and disorders; pharmaceutical preparations for the treatment of cancer. FIRST USE: 20200131. FIRST USE IN COMMERCE: 20200131

International Codes:5
U.S. Codes:006,018,044,046,051,052
Type CodeType
GS0051Pharmaceutical preparations for the treatment of autoimmune, cardiovascular, central nervous system, endocrine, gastrointestinal, genetic, immunological, infectious, inflammatory, menopausal, metabolic, musculoskeletal, neurodegenerative, neurological, neuromuscular, ophthalmological, psychiatric, respiratory, urogenital, urological and viral diseases and disorders; pharmaceutical preparations for the treatment of blood disorders, liver disorders, erectile dysfunction, sexual dysfunction, cancer, pain and diabetes; pharmaceutical preparations, namely, anti-fungal preparations, dermatological preparations and smoking cessation preparations; vaccines for human use
GS0051Pharmaceutical preparations for the treatment of autoimmune, and inflammatory diseases and disorders; pharmaceutical preparations for the treatment of cancer

Trademark Filing History

DescriptionDateProceeding Number
REGISTERED-PRINCIPAL REGISTER2020-10-13
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED2020-09-09
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED2020-09-08
STATEMENT OF USE PROCESSING COMPLETE2020-08-2665362
CASE ASSIGNED TO INTENT TO USE PARALEGAL2020-08-2665362
USE AMENDMENT FILED2020-08-1265362
TEAS STATEMENT OF USE RECEIVED2020-08-12
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED2020-07-28
TEAS EXTENSION RECEIVED2020-07-24
EXTENSION 3 GRANTED2020-07-2498765
EXTENSION 3 FILED2020-07-2498765
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED2020-01-14
TEAS EXTENSION RECEIVED2020-01-10
EXTENSION 2 GRANTED2020-01-1098765
EXTENSION 2 FILED2020-01-1098765
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED2019-08-01
TEAS EXTENSION RECEIVED2019-07-30
EXTENSION 1 GRANTED2019-07-3098765
EXTENSION 1 FILED2019-07-3098765
NOA E-MAILED - SOU REQUIRED FROM APPLICANT2019-02-05
PUBLISHED FOR OPPOSITION2018-12-11
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED2018-12-11
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED2018-11-21
APPROVED FOR PUB - PRINCIPAL REGISTER2018-10-26
ASSIGNED TO EXAMINER2018-10-2377986
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM2018-07-07
NEW APPLICATION ENTERED IN TRAM2018-07-05

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed